Main results of a national multicenter study assessing the compliance of pediatric centers to Italian Society of Neonatology recommendations on prevention of respiratory syncytial virus infection.
Macagno
Franco
F
U.O. di Neonatologia, Azienda Ospedaliera S. Maria della Misericordia, Udine. pastpresident@sin-neonatologia.it
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006776:Hospitals, Pediatric / Q000706:statistics & numerical data*; D006801:Humans; D007231:Infant, Newborn; D007558:Italy; D009359:Neonatology / Q000706:statistics & numerical data*; D000069455:Palivizumab; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy / Q000517:prevention & control*; D018113:Respiratory Syncytial Virus, Human / Q000187:drug effects; D012307:Risk Factors; D012955:Societies, Medical
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab